A major response to carboplatin in a metastatic triple-negative breast cancer patient with somatic mutation of BRCA1 and RAD51B: When chemotherapy meets precision medicine

L. Seguin , M. Chaffanet (1) , R. Sabatier (1) , A. Jose (1) , S. Garnier (1) , N. Carbuccia (1) , A. Guille (1) , D. Birnbaum (1) , F. Bertucci (1) , A. Goncalves (1)

1 CRCM - Centre de Recherche en Cancérologie de Marseille

Domains: Life Sciences [q-bio]

L. Seguin, M. Chaffanet, R. Sabatier, A. Jose, S. Garnier, et al.. A major response to carboplatin in a metastatic triple-negative breast cancer patient with somatic mutation of BRCA1 and RAD51B: When chemotherapy meets precision medicine. Annals of Oncology, 2018, 29 (6), ⟨10.1093/annonc/mdy314.030⟩. ⟨hal-02143656⟩